Sundar PichaiSundar Pichai earned $164M in 2023

Clay Siegall holds a significant investment in Immunome. In 2023, he received stock options for 2,137,080 shares, which vest over four years if he remains with the company. This grant highlights his strong belief in Immunome’s future and aligns his...

Stock Sold

$2.97M

RARE

$2.97M

34,750 RARE shares

What if they kept their stock?

If Clay Siegall, Ph.D. didn't sell their stock, today they would have:
Extra RARE34,750 shares worth $1.50M.
This is -49.6% and $1.47M less than what they got when they sold the stock.

Recent Insider Trades

RARE

$964.52K

RARE at $85.01/share

Aug 7, 2020

Sale

RARE

$2.00M

RARE at $85.55/share

Aug 7, 2020

Sale

RARE

2,550 shares

RARE

Jun 26, 2020

Received

RARE

3,000 shares

RARE

Jun 11, 2019

Received

RARE

3,000 shares

RARE

Jun 19, 2018

Received

RARE

1,875 shares

RARE

Jun 22, 2017

Received

RARE

1,875 shares

RARE

Jun 9, 2016

Received

Clay Siegall, Ph.D.

Founder and CEO of Immunome

I

View Compensation History

2023 Total Compensation

$650.98K

Salary

$162.50K

Bonus

$483.60K

Stock

$0.00

Other

$4.88K